Cordance or Antidepressant Treatment Response (ATR) index?

Psychiatry Research

Volumn 180, Issue 1, 2010, Pages 60-

  Kuo, Chi Chung ^a   Tsai, Jui Feng ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE;

ALPHA RHYTHM; ANTIDEPRESSANT TREATMENT RESPONSE INDEX; BRAIN REGION; CALCULATION; ELECTROENCEPHALOGRAPHY; HUMAN; LETTER; MAJOR DEPRESSION; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUANTITATIVE ANALYSIS; REFERENCE VALUE; REMISSION; THETA RHYTHM; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER; ELECTROENCEPHALOGRAPHY; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 77958176788     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.12.014     Document Type: Letter

References (7)

1. Cook I.A., Leuchter A.F., Uijtdehaage S.H., Osato S., Holschneider D.H., Abrams M., Rosenberg-Thompson S. Altered cerebral energy utilization in late life depression. Journal of Affective Disorders 1998, 49:89-99.
2. Cook I.A., Leuchter A.F., Witte E., Abrams M., Uijtdehaage S.H., Stubbeman W., Rosenberg-Thompson S., Anderson-Hanley C., Dunkin J.J. Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Research 1999, 85:263-273.
3. Cook I.A., Leuchter A.F., Morgan M., Witte E., Stubbeman W.F., Abrams M., Rosenberg S., Uijtdehaage S.H. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 2002, 27:120-131.
4. Cook I.A., Leuchter A.F., Morgan M.L., Stubbeman W., Siegman B., Abrams M. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. Journal of Psychiatric Research 2005, 39:461-466.
5. Leuchter A.F., Cook I.A., Mena I., Dunkin J.J., Cummings J.L., Newton T.F., Migneco O., Lufkin R.B., Walter D.O., Lachenbruch P.A. Assessment of cerebral perfusion using quantitative EEG cordance. Psychiatry Research 1994, 55:141-152.
6. Leuchter A.F., Cook I.A., DeBrota D.J., Hunter A.M., Potter W.Z., McGrouther C.C., Morgan M.L., Abrams M., Siegman B. Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clinical EEG and Neuroscience 2008, 39:175-181.
7. Leuchter A.F., Cook I.A., Marangell L.B., Gilmer W.S., Burgoyne K.S., Howland R.H., Trivedi M.H., Zisook S., Jain R., McCracken J.T., Fava M., Iosifescu D., Greenwald S. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Research 2009, 169:124-131.